Concert Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Concert Wealth Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,722	Closed	-$237K	–	699
2016 Q3	$237K	Sell	4,722 -753	-14%	-$38.2K	0.03%	573
2016 Q2	$262K	Buy	5,475 +213	+4%	+$10.1K	0.04%	514
2016 Q1	$240K	Sell	5,262 -897	-15%	-$42K	0.03%	536
2015 Q4	$334K	Buy	6,159 +111	+2%	+$5.84K	0.04%	447
2015 Q3	$300K	Buy	6,048 +807	+15%	+$46.3K	0.04%	481
2015 Q2	$306K	Buy	+5,241	New	+$306K	0.04%	486
2015 Q1	–	Sell	-5,073	Closed	-$257K	–	549
2014 Q4	$257K	Sell	5,073 -36	-0.7%	-$1.75K	0.04%	510
2014 Q3	$238K	Sell	5,109 -1,704	-25%	-$76.9K	0.03%	446
2014 Q2	$296K	Sell	6,813 -348	-5%	-$15K	0.04%	416
2014 Q1	$299K	Buy	+7,161	New	+$300K	0.04%	405

Other funds holding IHE

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAG

Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

BWL

Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Spinnaker Trust Portland, Maine $2.06B AUM 24.94% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Concert Wealth Management's IHE Position: Q4 2016 in Review

Concert Wealth Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2016, closing a stake of 4,722 shares — an estimated $237K sold.

Concert Wealth Management first reported a position in IHE in Q1 2014 and held it in 10 quarters. The position peaked at $334K in Q4 2015. 92 funds tracked by Wall St. Rank hold IHE as of Q4 2016.

Concert Wealth Management reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2016 after selling out during the quarter.
Concert Wealth Management sold 4,722 iShares US Pharmaceuticals ETF shares in Q4 2016, an estimated $237K.
Concert Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2014 and held it in 10 quarters.
Concert Wealth Management's iShares US Pharmaceuticals ETF position peaked at $334K in Q4 2015.
92 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2016.

Based on Concert Wealth Management's 13F filing for Q4 2016, filed 10 Feb 2017.